Remark (MARK) 10-Q 6 Jul 20 2020 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2020	Jul. 03, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	001-33720
Entity Registrant Name	Remark Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	33-1135689
Entity Address, Address Line One	800 S. Commerce St.
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89106
City Area Code	702
Local Phone Number	701-9514
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	MARK
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		99,408,916
Entity Central Index Key	0001368365
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 1,617	$ 272
Trade accounts receivable, net	1,540	1,964
Receivable from related parties	531	0
Prepaid expense and other current assets	4,617	4,623
Total current assets	8,305	6,859
Property and equipment, net	180	341
Operating lease assets	314	4,359
Investment in unconsolidated affiliates	1,934	1,935
Intangibles, net	490	509
Other long-term assets	773	824
Total assets	11,996	14,827
Liabilities and Stockholders’ Deficit
Accounts payable	8,525	8,126
Accrued expense and other current liabilities	13,307	14,326
Contract liability	367	313
Note payable	3,000	3,000
Loans payable, current, net of unamortized discount and debt issuance cost	11,931	12,025
Total current liabilities	37,130	37,790
Operating lease liabilities, long-term	79	4,650
Warrant liability	58	115
Total liabilities	37,267	42,555
Commitments and contingencies (Note 13)
Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued	0	0
Common stock, $0.001 par value; 100,000,000 shares authorized; 66,133,888 and 51,055,159 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	66	51
Additional paid-in-capital	323,958	319,275
Accumulated other comprehensive income	(45)	(227)
Accumulated deficit	(349,250)	(346,827)
Total stockholders’ deficit	(25,271)	(27,728)
Total liabilities and stockholders’ deficit	$ 11,996	$ 14,827

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (shares)	1,000,000	1,000,000
Preferred stock, shares issued (shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (shares)	100,000,000	100,000,000
Common stock, shares issued (shares)	66,133,888	51,055,159
Common stock, shares outstanding (shares)	66,133,888	51,055,159

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue	$ 431	$ 1,209
Cost and expense
Cost of revenue (excluding depreciation and amortization)	21	1,593
Sales and marketing	416	859
Technology and development	648	1,304
General and administrative	2,740	2,977
Depreciation and amortization	90	325
Other operating expense	0	6
Total cost and expense	3,915	7,064
Operating loss	(3,484)	(5,855)
Other income (expense)
Interest expense	(461)	(387)
Other income (expense), net	0	(45)
Change in fair value of warrant liability	57	(1,416)
Gain on lease termination	1,538	0
Other loss, net	(73)	(26)
Total other income (expense), net	1,061	(1,874)
Loss from continuing operations before income taxes	(2,423)	(7,729)
Benefit from income taxes	0	0
Loss from continuing operations	(2,423)	(7,729)
Loss from discontinued operations, net of tax (Note 17)	0	(1,123)
Net loss	(2,423)	(8,852)
Other comprehensive income (loss)
Foreign currency translation adjustments	182	(94)
Comprehensive loss	$ (2,241)	$ (8,946)
Weighted-average shares outstanding, basic and diluted (in shares)	53,775	39,258
Net loss per share, basic and diluted
Continuing operations (usd per share)	$ (0.05)	$ (0.20)
Discontinued operations (usd per share)	0	(0.03)
Consolidated (usd per share)	$ (0.05)	$ (0.23)

Condensed Consolidated Statemen

Condensed Consolidated Statements of Stockholders Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (shares) at Dec. 31, 2018		39,053,312
Beginning balance at Dec. 31, 2018	$ (13,124)	$ 39	$ 308,018	$ 32	$ (321,213)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,852)				(8,852)
Share-based compensation	98		98
Common stock sales (in shares)		1,666,667
Common stock issued	2,500	$ 2	2,498
Equity instrument exercises (in shares)		2,250
Equity instrument exercises	4		4
Other	(94)			(94)
Ending balance (shares) at Mar. 31, 2019		40,722,229
Ending balance at Mar. 31, 2019	$ (19,468)	$ 41	310,618	(62)	(330,065)
Beginning balance (shares) at Dec. 31, 2019	51,055,159	51,055,159
Beginning balance at Dec. 31, 2019	$ (27,728)	$ 51	319,275	(227)	(346,827)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,423)				(2,423)
Share-based compensation	47		47
Common stock sales (in shares)		15,078,729
Common stock issued	4,651	$ 15	4,636
Other	$ 182			182
Ending balance (shares) at Mar. 31, 2020	66,133,888	66,133,888
Ending balance at Mar. 31, 2020	$ (25,271)	$ 66	$ 323,958	$ (45)	$ (349,250)

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Cash Flows [Abstract]
Net cash used in continuing operating activities	$ (2,810)	$ (5,969)
Net cash provided in discontinued operating activities	0	5,898
Net cash used in operating activities	(2,810)	(71)
Cash flows from investing activities:
Payment of payroll costs capitalized to software in progress	0	(83)
Net cash provided by (used in) continuing investing activities	0	(83)
Net cash used in discontinued investing activities	0	(247)
Net cash used in investing activities	0	(330)
Cash flows from financing activities:
Proceeds from issuance of common stock, net	4,627	2,504
Repayments of debt	(472)	0
Net cash provided by financing activities	4,155	2,504
Net change in cash, cash equivalents and restricted cash	1,345	2,103
Cash, cash equivalents and restricted cash:
Beginning of period, including cash in disposal group	272	25,548
End of period	1,617	27,651
Supplemental cash flow information:
Cash paid for interest	0	13
Supplemental schedule of non-cash investing and financing activities:
Capitalization of interest to debt principal	$ 378	$ 0

ORGANIZATION AND BUSINESS

ORGANIZATION AND BUSINESS	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BUSINESS	NOTE 1. ORGANIZATION AND BUSINESS Organization and Business Remark Holdings, Inc. and subsidiaries (“Remark”, “we”, “us”, or “our”), which include its consolidated variable-interest entities (“VIEs”), are primarily technology-focused. Our KanKan data intelligence platform serves as the basis for our development and deployment of artificial-intelligence-based (“AI-based”) solutions for businesses in many industries and geographies. We also own and operate an e-commerce digital media property focused on a luxury beach lifestyle. Our common stock is listed on the Nasdaq Capital Market under the ticker symbol MARK. We recognize revenue primarily from sales of AI-based products and services from our KanKan business. COVID-19 Our unaudited condensed consolidated interim financial statements for the three months ended March 31, 2020 were impacted by the effects of the global outbreak of a novel strain of coronavirus, or COVID-19, as national and local governmental authorities in China and the U.S., where we operate, have placed significant restrictions on travel and other activities within their respective countries, leading to extended business closures. The restrictions and resulting business closures have limited our operational capabilities, which could have a material adverse impact on our business and which have created significant uncertainties, such as the potential adverse effect of the pandemic on the economy, our vendors, our employees and customers and customer sentiment in general. The extent of the impact of the pandemic on our business and financial results will depend largely on future developments, including the duration and severity of the outbreak, the length of the travel restrictions and business closures imposed by domestic and foreign governments, the impact on capital and financial markets and the related impact on the financial circumstances of our customers, all of which are highly uncertain and cannot be predicted. The pandemic-related situation is changing rapidly, and additional impacts of which we are not currently aware may arise. We are closely monitoring developments in the U.S. and in China and are continually assessing the potential impact on our business. To mitigate the potential material negative effects that COVID-19 may have on our business and to do our part to provide customers with the means to limit the spread of COVID-19, we have repurposed and improved our existing urban life cycle solution that we were selling to make schools in China “smart” schools to build a new product line of high-quality, highly-effective thermal imaging solutions that leverage our innovative software to provide customers with the ability to scan crowds and areas of high foot traffic for indications that certain persons may require secondary screening. We have begun sales efforts primarily in the U.S., as well as in other countries, though no revenue was recognized from this new product line during the three months ended March 31, 2020 . Going Concern During the three months ended March 31, 2020 , and in each fiscal year since our inception, we have incurred net losses which have resulted in an accumulated deficit of $349.3 million as of March 31, 2020 . Additionally, our operations have historically used more cash than they have provided. Net cash used in continuing operating activities was $2.8 million during the three months ended March 31, 2020 . As of March 31, 2020 , our cash and cash equivalents balance was $1.6 million , and we had a negative working capital balance of $28.8 million . On March 3, 2020, we entered into a common stock purchase agreement (the “2020 Aspire Purchase Agreement”) with Aspire Capital Fund, LLC (“Aspire Capital”) which provides that, upon the terms and subject to the conditions and limitations set forth therein, we have the right to direct Aspire Capital to purchase up to an aggregate of $30.0 million of shares of our common stock over the 30 -month term of the 2020 Aspire Purchase Agreement. The 2020 Aspire Purchase Agreement, which we describe in more detail in Note 14 , terminated and replaced the common stock purchase agreement we had entered into with Aspire Capital on March 29, 2019 (the “2019 Aspire Purchase Agreement”). Concurrently with entering into the 2020 Aspire Purchase Agreement, we also entered into a registration rights agreement with Aspire Capital, in which we agreed to file with the Securities and Exchange Commission (the “SEC”) one or more registration statements, as necessary, and to the extent permissible and subject to certain exceptions, to register under the Securities Act of 1933, as amended, the sale of the shares of our common stock that may be issued to Aspire Capital under the 2020 Aspire Purchase Agreement. We have filed with the SEC a prospectus supplement to our effective shelf Registration Statement on Form S-3 (File No. 333-225448) registering all of the shares of common stock that may be offered to Aspire Capital from time to time under the 2020 Aspire Purchase Agreement. As of March 31, 2020 , we have issued to Aspire Capital a total of 11,007,726 shares of our common stock under the 2020 Aspire Purchase Agreement. During the three months ended March 31, 2020 , we issued a total of 15,018,729 shares of our common stock to Aspire Capital under the 2019 Aspire Purchase Agreement and the 2020 Aspire Purchase Agreement in exchange for approximately $4.6 million plus Aspire Capital’s commitment to participate in the 2020 Aspire Purchase Agreement. We are a party to a financing agreement dated as of September 24, 2015 (as amended, the “Financing Agreement”) with certain of our subsidiaries as borrowers (together with Remark, the “Borrowers”), certain of our subsidiaries as guarantors (the “Guarantors”), the lenders from time to time party thereto (the “Lenders”) and MGG Investment Group LP (“MGG”), in its capacity as collateral agent and administrative agent for the Lenders, pursuant to which the Lenders extended credit to the Borrowers consisting of a term loan in the aggregate principal amount of $35.5 million (the “Loan”). The terms of the Financing Agreement, the amendments thereto, and related documents effective as of March 31, 2020 are described in Note 12 , which also describes our ongoing events of default relating to our failure to make certain required payments under the Financing Agreement as well as certain other ongoing events of default. Our history of recurring operating losses, working capital deficiencies and negative cash flows from operating activities, in conjunction with the ongoing events of default under the Financing Agreement, give rise to substantial doubt regarding our ability to continue as a going concern. We intend to fund our future operations and meet our financial obligations through revenue growth in our Technology and Data Intelligence segment, as well as through sales of our thermal-imaging products. We cannot, however, provide assurance that revenue, income and cash flows generated from our businesses will be sufficient to sustain our operations in the twelve months following the filing of this Form 10-Q. As a result, we are actively evaluating strategic alternatives including equity financings and potential sales of investment assets or operating businesses. Conditions in the debt and equity markets, as well as the volatility of investor sentiment regarding macroeconomic and microeconomic conditions (in particular, in response to the COVID-19 pandemic), will play primary roles in determining whether we can successfully obtain additional capital. We cannot be certain that we will be successful at raising additional capital. A variety of factors, many of which are outside of our control, affect our cash flow; those factors include the effects of the COVID-19 pandemic, regulatory issues, competition, financial markets and other general business conditions. Based on financial projections, we believe that we will be able to meet our ongoing requirements for at least the next 12 months with existing cash, cash equivalents and cash resources, and based on the probable success of one or more of the following plans: • develop and grow new product line(s) • monetize existing assets • obtain additional capital through equity issuances, including but not limited to equity issuances to Aspire Capital under its existing purchase commitment (which equity issuances may significantly dilute existing stockholders). However, projections are inherently uncertain and the success of our plans is largely outside of our control. As a result, there is substantial doubt regarding our ability to continue as a going concern, and we may fully utilize our cash resources prior to July 6, 2021 . Comparability For the quarter ended March 31, 2019, we have adjusted the presentation of the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss as well as for the Unaudited Condensed Consolidated Statement of Cash Flows to reflect the operations of our former Travel and Entertainment segment as discontinued, so that such presentation is consistent with the 2020 presentation.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES We prepared the accompanying unaudited Condensed Consolidated Balance Sheet as of March 31, 2020 , with the audited Consolidated Balance Sheet amounts as of December 31, 2019 presented for comparative purposes, and the related unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss, the Condensed Consolidated Statements of Cash Flows and the Condensed Consolidated Statements of Stockholders’ Deficit in accordance with the instructions for Form 10-Q. In compliance with those instructions, we have omitted certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), though management believes the disclosures made herein are sufficient to ensure that the information presented is not misleading. Our results of operations and our cash flows as of the end of the interim periods reported herein do not necessarily indicate the results we may experience for the remainder of the year or for any other future period. Management believes that we have included all adjustments (including those of a normal, recurring nature) considered necessary to fairly present our unaudited Condensed Consolidated Balance Sheet and our unaudited Condensed Consolidated Statement of Stockholders’ Deficit, each as of March 31, 2020 , as well as our unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss and Condensed Consolidated Statements of Cash Flows for all periods presented. You should read our unaudited condensed consolidated interim financial statements and footnotes in conjunction with our consolidated financial statements and footnotes included within the Annual Report on Form 10-K (the “ 2019 Form 10-K”). Consolidation We include all of our subsidiaries, which include the variable-interest entities (“VIEs”) for which we are the primary beneficiary, in our condensed consolidated financial statements, eliminating all significant intercompany balances and transactions during consolidation. To comply with China’s laws which restrict foreign ownership of entities that operate within industries deemed sensitive by the Chinese government, we employ what we believe is a commonly-used organizational structure consisting of a wholly-foreign owned enterprise (“WFOE”) and the VIEs to operate our KanKan business. We own 100% of the equity of the WFOE, while the VIEs are companies formed in China under local laws which are owned by members of our management team. We funded the registered capital and operating expenses of the VIEs by extending loans to the VIEs’ owners. We are the primary beneficiary of the VIEs because the relationships between the VIEs and our WFOE are governed by contractual agreements, including in each case an Exclusive Call Option Agreement, an Exclusive Business Cooperation Agreement, a Proxy Agreement and an Equity Pledge Agreement, which give us control over the operations of the VIEs. We use the fair value method to account for equity investments in which we cannot exercise significant influence over the investee, such as with our investment in Sharecare, Inc. (“Sharecare”). With regard to our investment in Sharecare, GAAP allows us to continue to carry our investment at cost less impairment until such time as an observable price change in the underlying security occurs. Any gains or losses resulting from a change in fair value are recorded to the statement of operations. We use the equity method for equity investments in which we can exercise significant influence over the investee, such as our investment in Beijing All-in-one Cloud Net Technology, Co. Ltd. (“AIO”) (see Note 6 for information on our investments in unconsolidated affiliates). Use of Estimates We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, intangible assets, the useful lives of property and equipment, stock-based compensation, the fair value of the warrant liability, income taxes, inventory reserve and purchase price allocation, among other items. As of March 31, 2020, the impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods. Recently Issued Accounting Pronouncements We have reviewed all recently issued accounting pronouncements. The pronouncements that we have already adopted, did not have a material effect on our financial condition, results of operations, cash flows or reporting thereof, we do not believe that any of the pronouncements that we have not yet adopted will have a material effect upon our financial condition, results of operations, cash flows or reporting thereof.

REVENUE

REVENUE	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
REVENUE	NOTE 3. REVENUE We are not required to include disclosures related to remaining performance obligations because substantially all of our contracts with customers have an original expected duration of one year or less. Disaggregation of Revenue The following table presents a disaggregation of our revenue by major category (in thousands): Three Months Ended March 31, 2020 2019 AI-based products and services $ 324 $ 425 Advertising and other 107 784 Revenue $ 431 $ 1,209 Significant Judgments When accounting for revenue we make certain judgments, such as whether we act as a principal or as an agent in transactions or whether our contracts with customers fall within the scope of current GAAP regarding revenue, that affect the determination of the amount and timing of our revenue from contracts with customers. Based on the current facts and circumstances related to our contracts with customers, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted in terms of their potential impact on the amount and timing of our revenue. Contract Assets and Contract Liabilities We do not currently generate material contract assets. During the three months ended March 31, 2020 , our contract liability changed only as a result of routine business activity. During the three months ended March 31, 2020 , we did no t recognize material amounts of revenue which were included in the beginning balance of Contract liability at January 1, 2020, while we recognized $0.1 million of revenue during the three months ended March 31, 2019 which was included in the beginning balance of Contract liability at January 1, 2019. During the three months ended March 31, 2020 and 2019 , we did not recognize revenue from performance obligations within the scope of ASC 606 that were satisfied in previous periods.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 4. FAIR VALUE MEASUREMENTS Liabilities Related to Warrants to Purchase Common Stock At the end of each reporting period, we use the Monte Carlo Simulation model to estimate and report the fair value of liabilities related to certain outstanding warrants to purchase common stock. As of March 31, 2020 , our outstanding liability-classified warrants include the warrants we issued or that we are obligated to issue as part of the consideration for our acquisition (the “CBG Acquisition”) of assets of China Branding Group Limited (“CBG”) in September 2016 (the “CBG Acquisition Warrants”) and warrants we issued as a result of an amendment to the Financing Agreement related to the acquisition (the “CBG Financing Warrants”). The following table presents the quantitative inputs, which we classify in Level 3 of the fair value hierarchy, used in estimating the fair value of the warrants: March 31, December 31, 2020 2019 CBG Financing Warrants Expected volatility 85.00 % 85.00 % Risk-free interest rate 0.33 % 1.60 % Expected remaining term (years) 0.48 0.73 CBG Acquisition Warrants Expected volatility 75.00 % 75.00 % Risk-free interest rate 0.52 % 1.65 % Expected remaining term (years) 3.48 3.72 In addition to the quantitative assumptions above, we also consider whether we would issue additional equity and, if so, the price per share of such equity. At March 31, 2020 , we estimated that one future equity financing event would potentially occur within the subsequent twelve months. Our estimate of expected volatility and our stock price tend to have the most significant impact on the estimated fair value of the CBG Financing Warrants and the CBG Acquisition Warrants. We determined that, for the three months ended March 31, 2020 , adding or subtracting five percentage points with regard to our estimate of expected volatility, or increases or decreases in our stock price of five percent, would not have resulted in changes to our estimates of fair value, except as follows: Increase Decrease Change in volatility CBG Acquisition Warrants — 58 The following table presents the change in the liability balance associated with our liability-classified warrants (in thousands): Three Months Ended March 31, Year Ended December 31, 2020 2019 Balance at beginning of period $ 115 $ 1,383 Decrease in fair value (57 ) (1,268 ) Balance at end of period $ 58 $ 115 Contingent Consideration Issued in Business Acquisition We used the discounted cash flow valuation technique to estimate the fair value of the liability related to certain cash payments stipulated in our acquisition of Vegas.com, LLC (“Vegas.com”) in September 2015 that were contingent upon the performance of Vegas.com in the years ended December 31, 2016, 2017, and 2018 (the “Earnout Payments”). The significant unobservable inputs that we used, which we classify in Level 3 of the fair value hierarchy, were projected earnings before interest, taxes, depreciation and amortization (“EBITDA”), the probability of achieving certain amounts of EBITDA, and the rate used to discount the liability. The following table presents the change during the three months ended March 31, 2020 in the balance of the liability associated with the Earnout Payments (in thousands): Balance at beginning of period $ 1,086 Interest accrued on unpaid balance 17 Balance at end of period $ 1,103

TRADE ACCOUNTS RECEIVABLE

TRADE ACCOUNTS RECEIVABLE	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Trade Accounts Receivable	NOTE 5. TRADE ACCOUNTS RECEIVABLE March 31, December 31, 2019 Gross accounts receivable balance $ 3,762 $ 4,171 Allowance for bad debt (2,222 ) (2,207 ) Accounts receivable, net $ 1,540 $ 1,964 Generally, it is not unusual for Chinese entities to pay their vendors on longer timelines than the timelines typically observed in U.S. commerce. Trade receivables related to our AI projects (exclusive of certain financial technology (“FinTech”) services we provided) represent 63%

INVESTMENT IN UNCONSOLIDATED AF

INVESTMENT IN UNCONSOLIDATED AFFILIATES	3 Months Ended
	Mar. 31, 2020
Noncontrolling Interest [Abstract]
INVESTMENT IN UNCONSOLIDATED AFFILIATES	NOTE 6. INVESTMENT IN UNCONSOLIDATED AFFILIATES In 2009, we co-founded a U.S.-based venture, Sharecare, to build a web-based platform that simplifies the search for health and wellness information. The other co-founders of Sharecare were Dr. Mehmet Oz, HARPO Productions, Discovery Communications, Jeff Arnold and Sony Pictures Television. As of March 31, 2020 , we owned approximately 4.6% of Sharecare’s issued stock and maintained representation on its Board of Directors. During June 2018, one of our consolidated VIEs acquired a 20% interest in AIO, a Chinese technology company which provides consulting and data services to the Chinese film industry, in exchange for $1.0 million , a portion of which was paid as of March 31, 2020 , and a license to use our proprietary KanKan data intelligence platform in China. Based on our evaluation of the facts and circumstances related to the transaction, we determined that we will account for such transaction using the equity method of accounting. We recognize our equity in the net earnings or losses relating to AIO on a one-quarter reporting lag in our Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. For the three months ended March 31, 2020 , the amount of our equity in AIO’s net earnings for their quarter ended December 31, 2019 was not material.

PREPAID EXPENSE AND OTHER CURRE

PREPAID EXPENSE AND OTHER CURRENT ASSETS	3 Months Ended
	Mar. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSE AND OTHER CURRENT ASSETS	NOTE 7. PREPAID EXPENSE AND OTHER CURRENT ASSETS The following table presents the components of prepaid expense and other current assets (in thousands): March 31, December 31, 2019 Other receivables $ 3,679 $ 3,712 Prepaid expense 649 633 Deposits 12 7 Other current assets 277 271 Total $ 4,617 $ 4,623

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	3 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 8. PROPERTY AND EQUIPMENT Property and equipment consist of the following (in thousands, except estimated lives): Estimated Life March 31, December 31, 2019 Computers and equipment 3 987 989 Furniture and fixtures 3 23 23 Software 3 4,867 4,896 Leasehold improvements 10 11 114 Total property, equipment and software $ 5,888 $ 6,022 Less accumulated depreciation (5,708 ) (5,681 ) Total property, equipment and software, net $ 180 $ 341 For the three months ended March 31, 2020 and 2019 , depreciation (and amortization of software) expense was $0.1 million and $0.2 million , respectively.

LEASES

LEASES	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	NOTE 9. LEASES We lease office space and equipment under contracts we classify as operating leases. None of our leases are financing leases. As of March 31, 2020 , the current portion of our operating lease liability was $0.3 million and was reported in Accrued expense and other current liabilities on our unaudited Condensed Consolidated Balance Sheet. The following table presents the detail of our lease expense, net of sublease income, which is reported in General and administrative expense (in thousands): Three Months Ended 2020 2019 Operating lease expense $ 394 $ 318 Short-term lease expense 75 66 Lease expense $ 469 $ 384 We reported within continuing operating cash flows for the three months ended March 31, 2020 and 2019 , de minimis amounts and $0.1 million , respectively, of cash paid for amounts included in the measurement of operating lease liabilities. As of March 31, 2020 , our operating leases had a weighted-average remaining lease term of approximately 16 months, and we used a weighted-average discount rate of 12% to measure our operating lease liabilities. Maturity of Lease Liabilities The following table presents information regarding the maturities of our undiscounted remaining operating lease payments, with a reconciliation to the amount of the liabilities representing such payments as presented in our March 31, 2020 unaudited Condensed Consolidated Balance Sheet (in thousands): Operating lease liabilities maturing during the next: One year $ 337 Two years 84 Total undiscounted cash flows $ 421 Present value of cash flows $ 395 Lease liabilities on balance sheet: Short-term $ 316 Long-term 79 Total lease liabilities $ 395 The current portion of our operating lease liability, which we report in Accrued expense and other current liabilities on our unaudited Condensed Consolidated Balance Sheet, also includes approximately $1.5 million of estimated damages from the early termination of our former office located at 3960 Howard Hughes Parkway in Las Vegas. Significant Judgments When accounting for our leases, we make certain judgments, such as whether a contract contains a lease or what discount rate to use, that affect the determination of the amount of our lease assets and liabilities. Based on the current facts and circumstances related to our contracts, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 10. INTANGIBLE ASSETS The following table summarizes intangible assets by category (in thousands): March 31, 2020 December 31, 2019 Gross Amount Accumulated Net Amount Gross Amount Accumulated Net Amount Finite-lived intangible assets Domain names $ 1,256 $ (893 ) $ 363 $ 1,256 $ (874 ) $ 382 Other intangible assets 68 (68 ) — 68 (68 ) — $ 1,324 $ (961 ) $ 363 $ 1,324 $ (942 ) $ 382 Indefinite-lived intangible assets License to operate in China 127 127 127 127 Total intangible assets $ 1,451 $ 490 $ 1,451 $ 509 Total amortization expense was de minimis and $0.1 million for the three months ended March 31, 2020 and 2019 , respectively.

INCOME TAX

INCOME TAX	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAX	NOTE 11. INCOME TAX Our effective tax rate (“ETR”) from continuing operations was 0.0% for the three months ended March 31, 2020 . The quarterly ETR has not significantly differed from our historical annual ETR because we continue to maintain a full valuation allowance against our existing deferred tax assets. In response to the COVID-19 pandemic, many governments have enacted or are contemplating measures to provide aid and economic stimulus. The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), which was enacted on March 27, 2020 in the U.S., includes measures to assist companies, including temporary change to income and non-income-based tax laws. As of March 31, 2020, we do not currently expect the provisions of the CARES Act to have a material effect on current income tax expense or the realizability of deferred income tax assets. We will monitor additional guidance and impact that the CARES Act and other potential legislation may have on our income taxes

DEBT

DEBT	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
DEBT	NOTE 12. DEBT Short-Term Debt On April 12, 2017, we issued a short-term note payable in the principal amount of $3.0 million to a private lender in exchange for cash in the same amount. The agreement, which does not have a stated interest rate, required us to repay the note plus a fee of $115 thousand on the maturity date of June 30, 2017. The note is accruing interest at $500 per day on the unpaid principal until we repay the note in full. As of March 31, 2020 , we owe $3.3 million in principal and accrued interest. Other Debt The following table presents debt (in thousands) as of: March 31, December 31, 2019 Loan due May 2020 $ 11,931 $ 12,025 On September 24, 2015, we entered into the Financing Agreement, pursuant to which the Lenders provided us with the $27.5 million Loan. We entered into Amendment No. 1 to Financing Agreement on September 20, 2016 which, among other changes, increased the Loan by $8.0 million to a total aggregate principal amount of $35.5 million . As of March 31, 2020 , after amendments and other events described below, the Loan bore interest at three-month LIBOR (with a floor of 2% ) plus 11% per annum, payable monthly, and had a maturity date of May 15, 2020. As of March 31, 2020 , the applicable interest rate on the Loan was approximately 13% per annum. In connection with the Financing Agreement, we also entered into a security agreement dated as of September 24, 2015 (the “Security Agreement”) with the other Borrowers and the Guarantors for the benefit of MGG, as collateral agent for the Secured Parties referred to therein, to secure the obligations of the Borrowers and the Guarantors under the Financing Agreement. The Security Agreement provided for a first-priority lien on, and security interest in, all assets of Remark and our subsidiaries, subject to certain exceptions. On April 30, 2018, we entered into Amendment No. 4 and Waiver to Financing Agreement (the “Fourth Financing Amendment”), which provided for, among other things, (i) a reduction in the interest rate on the remaining amount outstanding under the Financing Agreement to three-month LIBOR plus 8.5% per annum, (ii) an extension of the maturity date under the Financing Agreement to September 30, 2020, (iii) a modification of certain of our covenants under the Financing Agreement, including covenants regarding capital expenditures, minimum value of certain of our assets, consolidated EBITDA of Vegas.com and its subsidiaries, and revenue generated by KanKan, (iv) an increase in the amount we are permitted to invest in our non-U.S. subsidiaries operating our KanKan business, (v) a waiver by the Lenders of certain events of default under the Financing Agreement, and (vi) prepayment by the Borrowers of $8.0 million principal amount outstanding and $3.5 million of exit fees under the Financing Agreement within 60 days following the date of the Fourth Financing Amendment. In consideration for the Lenders’ entry into the Fourth Financing Amendment, we also paid a closing fee of approximately $413 thousand . Effective as of June 29, 2018, we entered into Amendment No. 5 and Waiver to Financing Agreement (the “Fifth Financing Amendment”) pursuant to which the Lenders agreed, among other things, to extend the due date of the prepayments required by the Fourth Financing Amendment for up to three months , provided that we made extension payments on the first business day of each such month. The extension payments were $250,000 for each of the first two months and $500,000 for the third month, with the final extension period ending on September 28, 2018. We made the extension payments required by the Fifth Financing Amendment to extend the due date of the prepayments required by the Fourth Financing Amendment to September 28, 2018; however, we failed to prepay the $8.0 million principal amount and $3.5 million of exit fees due on such date. Such failure to make the required payments constituted an event of default under the Financing Agreement and as a result, from September 28, 2018, the Loan bore interest at three-month LIBOR plus 11.0% , the default interest rate. On May 15, 2019, we completed the sale of all of the issued and outstanding membership interests of Vegas.com, LLC (the “VDC Transaction”) and used the cash proceeds of $30 million to pay amounts due under the Financing Agreement, of which approximately $10 million remained outstanding after giving effect to the application of such cash proceeds. On the same date, in connection with the closing of the VDC Transaction, we entered into Amendment No. 6 and Waiver to Financing Agreement (the “Sixth Financing Amendment”), pursuant to which, among other things, (i) the Lenders waived all events of default under the Financing Agreement existing as of the date of the Sixth Financing Amendment, (ii) MGG released any and all liens in the equity interests of Vegas.com and its subsidiaries and their assets and properties, (iii) the Borrowers could add the amount of any accrued and unpaid interest to the outstanding principal amount of the Loan, (iv) the remaining principal amount outstanding under the Financing Agreement accrued interest at a rate equal to the three-month LIBOR (with a floor of 2% ) plus 8.5% per annum, (v) the continuing Loan had a maturity date of May 15, 2020, (vi) covenants with respect to capital expenditures and revenue generated by our KanKan business were eliminated and covenants regarding the minimum value of certain of our assets, our minimum liquidity and the amount we were permitted to invest in our non-U.S. subsidiaries were modified, and (vii) we were required to commence a sale process with respect to our equity in Sharecare within five business days of the effective date of the Sixth Financing Amendment, and to use the net cash proceeds of such sale to pay in full our outstanding obligations under the Financing Agreement the (“Sharecare Covenant”). The Financing Agreement contained certain affirmative and negative covenants. As of March 31, 2020 , we were not in compliance with certain of such covenants under the Financing Agreement, including a covenant requiring us to obtain and pay for a tail directors’ and officers’ liability insurance policy (the “Tail Policy”) by June 4, 2019 in connection with the VDC Transaction, and a covenant requiring us to make the final Earnout Payment by June 14, 2019. Additionally, although we have actively taken steps to monetize our ownership interest in Sharecare, we did not comply with certain procedural requirements stipulated by the Sharecare Covenant. Our non-compliance with such covenants constituted events of default under the Financing Agreement. In addition, in June 2019, the Lenders paid the $1.1 million of premium under the Tail Policy on our behalf and such amount was added to the amount of principal due under the Financing Agreement. See Note 13

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 13. COMMITMENTS AND CONTINGENCIES At March 31, 2020 , we had no material commitments outside the normal course of business. Contingencies As of March 31, 2020 , we were neither a defendant in any material pending legal proceeding nor are we aware of any material threatened claims against us and, therefore, we have not accrued any contingent liabilities, except as described below. Earnout Payment As of March 31, 2020 and December 31, 2019 , we have accrued approximately $1.1 million related to the Earnout Payment related to our acquisition of Vegas.com. See Note 4 for more information regarding the Earnout Payment. Termination of Lease and Related Landlord Actions Since approximately July 2019, we have not been able to pay our obligations under the office lease for our former office located at 3960 Howard Hughes Parkway. On March 5, 2020, the landlord exercised its right to terminate the lease as of such date as a result of the ongoing payment default. On April 9, 2020, the landlord filed suit against us in Nevada to recover the approximately $1.1 million of rent owed through March 5, 2020, plus damages resulting from the early termination of the lease. Based on calculations stipulated by the lease, we estimated the increase to rent expense and to the current portion of our operating lease liability, net of security deposit of $0.3 million , was approximately $1.5 million as of March 31, 2020 ; this amount is subject to change based upon future events. We have leased new office space under a lease that is not material to our consolidated financial statements. Lender Actions and Repayment of Debt On January 8, 2020, we received a notice from MGG that, as a result of certain continuing defaults under the Financing Agreement, the Lenders had exercised their right under the Financing Agreement to replace the single-member board of directors of our wholly-owned subsidiary that holds our investment (described in Note 6 ) in Sharecare with a person of their choosing. On March 16, 2020, we received a notice of acceleration from MGG, in which MGG declared that the entire unpaid principal of and any accrued and unpaid interest on the Loan, and all fees and other amounts payable under the Financing Agreement, are immediately due and payable and demanded that all such amounts be paid immediately to MGG. On March 16, 2020, MGG filed a Summons with Notice against us in the Supreme Court of the State of New York, County of New York, alleging a claim for breach of contract under the Financing Agreement. On May 28, 2020, we repaid in full all outstanding obligations under, and terminated, the Financing Agreement. As a result, we believe that there are no grounds for MGG’s lawsuit against us to continue. On the same date, and concurrently with repaying all outstanding obligations under the Financing Agreement, we agreed to reduce by $0.30 per share the exercise price of the CBG Financing Warrants to purchase 6,601,558 shares of our common stock. On June 23, 2020, MGG voluntarily discontinued the legal action against us in the Supreme Court of the State of New York, County of New York.

STOCKHOLDERS' EQUITY, STOCK-BAS

STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE	3 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE	NOTE 14. STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE Equity Issuances On March 3, 2020, we entered into the 2020 Aspire Purchase Agreement with Aspire Capital which provides that, upon the terms and subject to the conditions and limitations set forth therein, we have the right to direct Aspire Capital to purchase up to an aggregate of $30.0 million of shares of our common stock over the 30 -month term of the 2020 Aspire Purchase Agreement. The 2020 Aspire Purchase Agreement replaced the 2019 Aspire Purchase Agreement, which terminated under the terms of the 2020 Aspire Purchase Agreement. In consideration for entering into the 2020 Aspire Purchase Agreement, we have issued to Aspire Capital 2,374,545 shares of our common stock. Under the 2020 Aspire Purchase Agreement, on any trading day selected by us over the 30 -month term of the 2020 Aspire Purchase Agreement, we have the right, in our sole discretion, to present Aspire Capital with a purchase notice (each, a “Purchase Notice”) directing Aspire Capital to purchase up to 250,000 shares of our common stock per trading day, up to an aggregate of $30.0 million of our common stock, at a per share price equal to the lesser of (i) the lowest sale price of our common stock on the purchase date or (ii) the arithmetic average of the three lowest closing sale prices for our common stock during the 10 consecutive trading days ending on the trading day immediately preceding the purchase date. The aggregate purchase price payable by Aspire Capital on any one purchase date may not exceed $500,000 , unless otherwise mutually agreed. The parties may mutually agree to increase the number of shares of our common stock that may be purchased per trading day pursuant to the terms of the 2020 Aspire Purchase Agreement to an additional 2,000,000 shares. In addition, on any trading day on which we submit a Purchase Notice to Aspire Capital to purchase at least 250,000 shares, we also have the right, in our sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of our common stock equal to up to 30% of the aggregate shares of our common stock traded on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares we may determine, and a minimum purchase price threshold equal to the greater of (i) 80% of the closing price of our common stock on the trading day immediately preceding the VWAP Purchase Date or (ii) a higher price that may be determined by us. The purchase price per share pursuant to such VWAP Purchase Notice will be equal to the lesser of (i) the closing sale price of our common stock on the VWAP Purchase Date, or (ii) 97% of the volume-weighted average price for our common stock traded on its principal market on the VWAP Purchase Date. We may deliver multiple Purchase Notices and VWAP Purchase Notices to Aspire Capital from time to time during the term of the 2020 Aspire Purchase Agreement, so long as the most recent purchase has been completed. In addition, Aspire Capital will not be required to buy any shares of our common stock pursuant to a Purchase Notice on any trading day on which the closing trade price of our common stock is below $0.25 . There are no trading volume requirements or restrictions under the 2020 Aspire Purchase Agreement, and we will control the timing and amount of sales of our common stock to Aspire Capital. Aspire Capital has no right to require any sales by us, but is obligated to make purchases from us as directed by us in accordance with the 2020 Aspire Purchase Agreement. There are no limitations on use of proceeds, financial or business covenants, restrictions on future fundings, rights of first refusal, participation rights, penalties or liquidated damages in the 2020 Aspire Purchase Agreement. The 2020 Aspire Purchase Agreement may be terminated by us at any time, at our discretion, without any cost to us. Aspire Capital has agreed that neither it nor any of its agents, representatives and affiliates will engage in any direct or indirect short-selling or hedging our common stock during any time prior to the termination of the 2020 Aspire Purchase Agreement. The 2020 Aspire Purchase Agreement provides that the total number of shares that may be issued pursuant to such agreement is limited to 11,007,726 shares (the “Exchange Cap”), or 19.99% of our shares of common stock outstanding as of the date of the 2020 Aspire Purchase Agreement, unless stockholder approval is obtained in accordance with the rules of the Nasdaq Stock Market. If stockholder approval is not obtained, such limitation will not apply after the Exchange Cap is reached if at all times thereafter the average purchase price paid for all shares issued under the 2020 Aspire Purchase Agreement is equal to or greater than $0.4879 per share. The 2020 Aspire Purchase Agreement also provides that at no time will Aspire Capital (together with its affiliates) beneficially own more than 19.99% of our outstanding shares of common stock. See Note 18 for details regarding and amendment of the 2020 Aspire Purchase Agreement. As of March 31, 2020 , we have issued to Aspire Capital a total of 11,007,726 shares of our common stock under the 2020 Aspire Purchase Agreement. During the three months ended March 31, 2020 , we issued a total of 15,018,729 shares of our common stock to Aspire Capital under the 2019 Aspire Purchase Agreement and the 2020 Aspire Purchase Agreement in exchange for $4.6 million plus Aspire Capital’s commitment to participate in the 2020 Aspire Purchase Agreement. Stock-Based Compensation We are authorized to issue equity-based awards under our 2010 Equity Incentive Plan, our 2014 Incentive Plan, and our 2017 Incentive Plan, each of which our stockholders have approved. We also award cash bonuses (“China Cash Bonuses”) to our employees in China, which grants are not subject to a formal incentive plan and which can only be settled in cash. We grant such awards to attract, retain and motivate eligible officers, directors, employees and consultants. Under each of the plans, we have granted shares of restricted stock and options to purchase common stock to our officers and employees with exercise prices equal to or greater than the fair value of the underlying shares on the grant date. Stock options and China Cash Bonuses generally expire 10 years from the grant date. All forms of equity awards and China Cash Bonuses vest upon the passage of time, the attainment of performance criteria, or both. When participants exercise stock options, we issue any shares of our common stock resulting from such exercise from new authorized and unallocated shares available at the time of exercise. The following table summarizes activity under our equity incentive plans related to equity-classified stock option grants as of March 31, 2020 , and changes during the three months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 10,359,079 $ 4.20 Forfeited, cancelled or expired (68,250 ) 3.07 Outstanding at March 31, 2020 10,290,829 $ 4.21 6.5 $ — Options exercisable at March 31, 2020 9,900,705 $ 4.35 6.4 $ — The following table summarizes activity under our equity incentive plans related to the China Cash Bonuses as of March 31, 2020 , and changes during the three months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 1,087,500 $ 5.20 Forfeited, cancelled or expired (114,500 ) 5.40 Outstanding at March 31, 2020 973,000 $ 5.18 5.3 $ — Options exercisable at March 31, 2020 817,000 $ 5.20 4.8 $ — During the three months ended March 31, 2020 , we did not award restricted stock under our equity incentive plans. During the three months ended March 31, 2020 and 2019 , we incurred a de minimis amount of share-based compensation expense. Net Loss per Share For the three months ended March 31, 2020 and 2019 , there were no reconciling items related to either the numerator or denominator of the loss per share calculation. Securities which would have been anti-dilutive to a calculation of diluted earnings per share for the three months ended March 31, 2020 and 2019 include the outstanding stock options described above; the outstanding CBG Acquisition Warrant, which may be exercised to purchase 40,000 shares of our common stock at a per-share exercise price of $10.00 (we are also committed to the future issuance of additional CBG Acquisition Warrants at the same per-share exercise price as the CBG Acquisition Warrant that has already been issued); and the outstanding CBG Financing Warrants, which may be exercised to purchase 4,896,313 shares of our common stock at an exercise price of $3.00 per share.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 15. RELATED PARTY TRANSACTIONS As of March 31, 2020 , we had outstanding approximately $0.5 million of receivables from related parties. The receivables represent cash advances in excess of expense reimbursements to senior management. The cash to be received from these receivables will be injected as additional capital into our VIEs in China. As of July 6, 2020, the funds had not yet been deposited into the VIEs.

SEGMENT INFORMATION

SEGMENT INFORMATION	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
SEGMENT INFORMATION	NOTE 16. SEGMENT INFORMATION As a result of our disposal of the previously-reported Travel and Entertainment segment, we currently report one segment: our Technology & Data Intelligence segment, which provides services to our customers based upon the data collected and processed by our proprietary data intelligence software. Our chief operating decision maker uses Adjusted EBITDA as the primary measure of profitability for evaluating the operational performance of our reportable segment. Adjusted EBITDA represents operating income (loss) plus depreciation and amortization expense, share-based compensation expense, impairments and net other income, less other loss. We do not allocate certain types of shared expense, such as legal and accounting, to our reportable segment; such costs are included in Corporate Entity and Other. The following table presents certain financial information regarding our reportable segment and other entities for the three months ended March 31, 2020 and 2019 (in thousands): Technology & Data Intelligence Corporate Entity and Other Consolidated Three Months Ended March 31, 2020 Revenue $ 324 $ 107 $ 431 Adjusted EBITDA $ (690 ) $ (1,205 ) $ (1,895 ) Three Months Ended March 31, 2019 Revenue $ 425 $ 784 $ 1,209 Adjusted EBITDA $ (2,659 ) $ (2,617 ) $ (5,276 ) The following table reconciles Adjusted EBITDA to Loss before income taxes (in thousands): Three Months Ended March 31, 2020 2019 Adjusted EBITDA $ (1,895 ) $ (5,276 ) Depreciation and amortization (90 ) (325 ) Share-based compensation expense (35 ) (325 ) Other expense (income), net 1 45 Other loss (gain) (1,465 ) 26 Operating loss $ (3,484 ) $ (5,855 ) Other income (expense) Interest expense (461 ) (387 ) Other income (expense), net — (45 ) Gain on lease termination 1,538 — Change in fair value of warrant liability 57 (1,416 ) Other gain (loss), net (73 ) (26 ) Total other income (expense), net $ 1,061 $ (1,874 ) Income (Loss) from continuing operations before income taxes $ (2,423 ) $ (7,729 ) The following table presents total assets for our reportable segment and the corporate and other entities (in thousands): March 31, December 31, 2019 Technology & Data Intelligence segment $ 7,040 $ 7,450 Corporate entity and other business units 4,956 7,377 Consolidated $ 11,996 $ 14,827 Capital expenditures for our Technology & Data Intelligence segment were de minimis during the three months ended March 31, 2020 and totaled $0.1 million during the three months ended March 31, 2019 .

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	3 Months Ended
	Mar. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	NOTE 17. DISCONTINUED OPERATIONS On May 15, 2019, we completed the VDC Transaction for an aggregate purchase price of $30.0 million . The business we sold in the VDC Transaction formerly comprised our Travel and Entertainment segment. The following table presents the major classes of line items constituting the pretax profit or loss of the disposed Travel and Entertainment segment (in thousands): Three Months Ended March 31, 2019 Revenue $ 18,254 Cost of revenue (excluding depreciation and amortization) 2,776 Selling, general and administrative 10,877 Technology and development 2,198 Depreciation, amortization and impairments 2,147 Other operating expense 245 Other expense (income) and loss (gain), net 1,134 Loss from discontinued operations before income taxes (1,123 ) Benefit from income taxes — Loss from discontinued operations $ (1,123 )

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 18. SUBSEQUENT EVENTS Sales of Common Stock to Aspire Capital In a series of transactions between March 25, 2020 and May 12, 2020, we sold 41,853,345 shares of our common stock to Aspire Capital under the 2020 Aspire Purchase Agreement in exchange for $30.0 million . Our Amended and Restated Certificate of Incorporation authorizes us to issue up to 100,000,000 shares of our common stock, of which 99,408,916 shares were outstanding as of July 3, 2020 . In addition, as of July 3, 2020 , we had outstanding stock options allowing for the purchase of as many as approximately 10.3 million shares of common stock and we had outstanding warrants to purchase 6,641,558 shares of common stock. If all of our outstanding stock options and warrants were exercised, the total number of shares of our common stock that we would be required to issue would greatly exceed the number of our remaining authorized but unissued shares of common stock. As a result of such potential shortfall in the number of our authorized shares of common stock, we will have insufficient shares of common stock available to issue in connection with the exercise of our outstanding stock options and warrants or any future equity financing transaction we may seek to undertake. Accordingly, we intend to seek approval of an increase in the number of our authorized shares of common stock at our 2020 annual meeting of stockholders. Amendment to Common Stock Purchase Agreement On April 9, 2020, we entered into a First Amendment to the 2020 Aspire Purchase Agreement (the “Aspire Amendment”), which amends the 2020 Aspire Purchase Agreement to provide that (i) we may issue up to an additional 13,220,164 shares (the “New Exchange Cap”), or 19.99% of our shares of common stock outstanding as of the date of the Aspire Amendment, pursuant to the 2020 Aspire Purchase Agreement following the effective date of the Aspire Amendment, unless stockholder approval is obtained in accordance with the rules of the Nasdaq Stock Market, (ii) if stockholder approval is not obtained, such limitation will not apply after the New Exchange Cap is reached if at all times thereafter the average purchase price paid for all shares issued under the 2020 Aspire Purchase Agreement following the effective date of the Aspire Amendment is equal to or greater than $0.3950 per share, (iii) we have the right, in our sole discretion, to present Aspire Capital with a Purchase Notice directing Aspire Capital to purchase up to 500,000 shares of our common stock per trading day, (iv) the aggregate purchase price payable by Aspire Capital on any one purchase date may not exceed $1,000,000 , unless otherwise mutually agreed, (v) on any trading day on which we submit a purchase notice to Aspire Capital to purchase at least 500,000 shares of common stock, we also have the right, in our sole discretion, to present Aspire Capital with a VWAP Purchase Notice directing Aspire Capital to purchase an amount of our common stock equal to up to 30% of the aggregate shares of our common stock traded on the next trading day, (vi) the purchase price per share pursuant to such VWAP Purchase Notice will be equal to the lesser of (A) the closing sale price of our common stock on the VWAP Purchase Date, or (B) 95% of the volume-weighted average price for our common stock traded on its principal market on the VWAP Purchase Date, and (vii) Aspire Capital will not be required to buy any shares of our common stock pursuant to a Purchase Notice on any trading day on which the closing trade price of our common stock is below $0.15 . Landlord Actions On April 9, 2020, the landlord under the office lease for our former office located at 3960 Howard Hughes Parkway filed suit against us in Nevada to recover the approximately $1.1 million of rent owed plus damages resulting from the early termination of the lease. Based on calculations stipulated by the lease, we estimated the increase to rent expense and to the current portion of our operating lease liability, net of security deposit of $0.3 million , was approximately $1.5 million ; this amount is subject to change based upon future events. We recorded such amount during 2019, and we report it as part of the current portion of our operating lease liability within Accrued expense and other current liabilities as of March 31, 2020. Lender Actions and Repayment of Debt On May 28, 2020, we repaid in full all outstanding obligations under, and terminated, the Financing Agreement. On the same date, and concurrently with repaying all outstanding obligations under the Financing Agreement, we agreed to reduce by $0.30 per share the exercise price of the CBG Financing Warrants to purchase 6,601,558 shares of our common stock. On June 23, 2020, MGG voluntarily discontinued the legal action against us in the Supreme Court of the State of New York, County of New York.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Accounting	We prepared the accompanying unaudited Condensed Consolidated Balance Sheet as of March 31, 2020 , with the audited Consolidated Balance Sheet amounts as of December 31, 2019 presented for comparative purposes, and the related unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss, the Condensed Consolidated Statements of Cash Flows and the Condensed Consolidated Statements of Stockholders’ Deficit in accordance with the instructions for Form 10-Q. In compliance with those instructions, we have omitted certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), though management believes the disclosures made herein are sufficient to ensure that the information presented is not misleading. Our results of operations and our cash flows as of the end of the interim periods reported herein do not necessarily indicate the results we may experience for the remainder of the year or for any other future period. Management believes that we have included all adjustments (including those of a normal, recurring nature) considered necessary to fairly present our unaudited Condensed Consolidated Balance Sheet and our unaudited Condensed Consolidated Statement of Stockholders’ Deficit, each as of March 31, 2020 , as well as our unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss and Condensed Consolidated Statements of Cash Flows for all periods presented. You should read our unaudited condensed consolidated interim financial statements and footnotes in conjunction with our consolidated financial statements and footnotes included within the Annual Report on Form 10-K (the “ 2019 Form 10-K”).
Consolidation	Consolidation We include all of our subsidiaries, which include the variable-interest entities (“VIEs”) for which we are the primary beneficiary, in our condensed consolidated financial statements, eliminating all significant intercompany balances and transactions during consolidation. To comply with China’s laws which restrict foreign ownership of entities that operate within industries deemed sensitive by the Chinese government, we employ what we believe is a commonly-used organizational structure consisting of a wholly-foreign owned enterprise (“WFOE”) and the VIEs to operate our KanKan business. We own 100% of the equity of the WFOE, while the VIEs are companies formed in China under local laws which are owned by members of our management team. We funded the registered capital and operating expenses of the VIEs by extending loans to the VIEs’ owners. We are the primary beneficiary of the VIEs because the relationships between the VIEs and our WFOE are governed by contractual agreements, including in each case an Exclusive Call Option Agreement, an Exclusive Business Cooperation Agreement, a Proxy Agreement and an Equity Pledge Agreement, which give us control over the operations of the VIEs.
Use of Estimates	Use of Estimates We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, intangible assets, the useful lives of property and equipment, stock-based compensation, the fair value of the warrant liability, income taxes, inventory reserve and purchase price allocation, among other items. As of March 31, 2020, the impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements We have reviewed all recently issued accounting pronouncements. The pronouncements that we have already adopted, did not have a material effect on our financial condition, results of operations, cash flows or reporting thereof, we do not believe that any of the pronouncements that we have not yet adopted will have a material effect upon our financial condition, results of operations, cash flows or reporting thereof.

REVENUE (Tables)

REVENUE (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Schedule of disaggregation of revenue	The following table presents a disaggregation of our revenue by major category (in thousands): Three Months Ended March 31, 2020 2019 AI-based products and services $ 324 $ 425 Advertising and other 107 784 Revenue $ 431 $ 1,209

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Quantitative inputs	The following table presents the quantitative inputs, which we classify in Level 3 of the fair value hierarchy, used in estimating the fair value of the warrants: March 31, December 31, 2020 2019 CBG Financing Warrants Expected volatility 85.00 % 85.00 % Risk-free interest rate 0.33 % 1.60 % Expected remaining term (years) 0.48 0.73 CBG Acquisition Warrants Expected volatility 75.00 % 75.00 % Risk-free interest rate 0.52 % 1.65 % Expected remaining term (years) 3.48 3.72 Increase Decrease Change in volatility CBG Acquisition Warrants — 58
Reconciliation of liabilities of warrants	The following table presents the change in the liability balance associated with our liability-classified warrants (in thousands): Three Months Ended March 31, Year Ended December 31, 2020 2019 Balance at beginning of period $ 115 $ 1,383 Decrease in fair value (57 ) (1,268 ) Balance at end of period $ 58 $ 115
Reconciliation of earnout payments	The following table presents the change during the three months ended March 31, 2020 in the balance of the liability associated with the Earnout Payments (in thousands): Balance at beginning of period $ 1,086 Interest accrued on unpaid balance 17 Balance at end of period $ 1,103

TRADE ACCOUNTS RECEIVABLE (Tabl

TRADE ACCOUNTS RECEIVABLE (Tables)	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	March 31, December 31, 2019 Gross accounts receivable balance $ 3,762 $ 4,171 Allowance for bad debt (2,222 ) (2,207 ) Accounts receivable, net $ 1,540 $ 1,964

PREPAID EXPENSE AND OTHER CUR_2

PREPAID EXPENSE AND OTHER CURRENT ASSETS (Tables)	3 Months Ended
	Mar. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expense and other current assets	The following table presents the components of prepaid expense and other current assets (in thousands): March 31, December 31, 2019 Other receivables $ 3,679 $ 3,712 Prepaid expense 649 633 Deposits 12 7 Other current assets 277 271 Total $ 4,617 $ 4,623

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Property and equipment	Property and equipment consist of the following (in thousands, except estimated lives): Estimated Life March 31, December 31, 2019 Computers and equipment 3 987 989 Furniture and fixtures 3 23 23 Software 3 4,867 4,896 Leasehold improvements 10 11 114 Total property, equipment and software $ 5,888 $ 6,022 Less accumulated depreciation (5,708 ) (5,681 ) Total property, equipment and software, net $ 180 $ 341

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Lease expense, net of sublease income	The following table presents the detail of our lease expense, net of sublease income, which is reported in General and administrative expense (in thousands): Three Months Ended 2020 2019 Operating lease expense $ 394 $ 318 Short-term lease expense 75 66 Lease expense $ 469 $ 384
Maturity of lease liabilities	The following table presents information regarding the maturities of our undiscounted remaining operating lease payments, with a reconciliation to the amount of the liabilities representing such payments as presented in our March 31, 2020 unaudited Condensed Consolidated Balance Sheet (in thousands): Operating lease liabilities maturing during the next: One year $ 337 Two years 84 Total undiscounted cash flows $ 421 Present value of cash flows $ 395 Lease liabilities on balance sheet: Short-term $ 316 Long-term 79 Total lease liabilities $ 395

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-lived intangible assets	The following table summarizes intangible assets by category (in thousands): March 31, 2020 December 31, 2019 Gross Amount Accumulated Net Amount Gross Amount Accumulated Net Amount Finite-lived intangible assets Domain names $ 1,256 $ (893 ) $ 363 $ 1,256 $ (874 ) $ 382 Other intangible assets 68 (68 ) — 68 (68 ) — $ 1,324 $ (961 ) $ 363 $ 1,324 $ (942 ) $ 382 Indefinite-lived intangible assets License to operate in China 127 127 127 127 Total intangible assets $ 1,451 $ 490 $ 1,451 $ 509
Indefinite-lived intangible assets	The following table summarizes intangible assets by category (in thousands): March 31, 2020 December 31, 2019 Gross Amount Accumulated Net Amount Gross Amount Accumulated Net Amount Finite-lived intangible assets Domain names $ 1,256 $ (893 ) $ 363 $ 1,256 $ (874 ) $ 382 Other intangible assets 68 (68 ) — 68 (68 ) — $ 1,324 $ (961 ) $ 363 $ 1,324 $ (942 ) $ 382 Indefinite-lived intangible assets License to operate in China 127 127 127 127 Total intangible assets $ 1,451 $ 490 $ 1,451 $ 509

DEBT (Tables)

DEBT (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of long-term debt instruments	The following table presents debt (in thousands) as of: March 31, December 31, 2019 Loan due May 2020 $ 11,931 $ 12,025

STOCKHOLDERS' EQUITY, STOCK-B_2

STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Stock option activity under equity incentive plans	The following table summarizes activity under our equity incentive plans related to equity-classified stock option grants as of March 31, 2020 , and changes during the three months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 10,359,079 $ 4.20 Forfeited, cancelled or expired (68,250 ) 3.07 Outstanding at March 31, 2020 10,290,829 $ 4.21 6.5 $ — Options exercisable at March 31, 2020 9,900,705 $ 4.35 6.4 $ — The following table summarizes activity under our equity incentive plans related to the China Cash Bonuses as of March 31, 2020 , and changes during the three months then ended: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at January 1, 2020 1,087,500 $ 5.20 Forfeited, cancelled or expired (114,500 ) 5.40 Outstanding at March 31, 2020 973,000 $ 5.18 5.3 $ — Options exercisable at March 31, 2020 817,000 $ 5.20 4.8 $ —

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of segment reporting information, by segment	The following table presents certain financial information regarding our reportable segment and other entities for the three months ended March 31, 2020 and 2019 (in thousands): Technology & Data Intelligence Corporate Entity and Other Consolidated Three Months Ended March 31, 2020 Revenue $ 324 $ 107 $ 431 Adjusted EBITDA $ (690 ) $ (1,205 ) $ (1,895 ) Three Months Ended March 31, 2019 Revenue $ 425 $ 784 $ 1,209 Adjusted EBITDA $ (2,659 ) $ (2,617 ) $ (5,276 ) The following table reconciles Adjusted EBITDA to Loss before income taxes (in thousands): Three Months Ended March 31, 2020 2019 Adjusted EBITDA $ (1,895 ) $ (5,276 ) Depreciation and amortization (90 ) (325 ) Share-based compensation expense (35 ) (325 ) Other expense (income), net 1 45 Other loss (gain) (1,465 ) 26 Operating loss $ (3,484 ) $ (5,855 ) Other income (expense) Interest expense (461 ) (387 ) Other income (expense), net — (45 ) Gain on lease termination 1,538 — Change in fair value of warrant liability 57 (1,416 ) Other gain (loss), net (73 ) (26 ) Total other income (expense), net $ 1,061 $ (1,874 ) Income (Loss) from continuing operations before income taxes $ (2,423 ) $ (7,729 ) The following table presents total assets for our reportable segment and the corporate and other entities (in thousands): March 31, December 31, 2019 Technology & Data Intelligence segment $ 7,040 $ 7,450 Corporate entity and other business units 4,956 7,377 Consolidated $ 11,996 $ 14,827

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	3 Months Ended
	Mar. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The following table presents the major classes of line items constituting the pretax profit or loss of the disposed Travel and Entertainment segment (in thousands): Three Months Ended March 31, 2019 Revenue $ 18,254 Cost of revenue (excluding depreciation and amortization) 2,776 Selling, general and administrative 10,877 Technology and development 2,198 Depreciation, amortization and impairments 2,147 Other operating expense 245 Other expense (income) and loss (gain), net 1,134 Loss from discontinued operations before income taxes (1,123 ) Benefit from income taxes — Loss from discontinued operations $ (1,123 )

ORGANIZATION AND BUSINESS (Deta

ORGANIZATION AND BUSINESS (Details) - USD ($)	Mar. 03, 2020	Mar. 29, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Sep. 20, 2016	Sep. 24, 2015
Debt Instrument [Line Items]
Accumulated deficit			$ 349,250,000		$ 346,827,000
Net cash used in operating activities			2,810,000	$ 5,969,000
Cash and cash equivalents			1,617,000		$ 272,000
Working capital			$ 28,800,000
Loans Payable
Debt Instrument [Line Items]
Aggregate principal amount						$ 35,500,000	$ 27,500,000
Aspire Capital Fund, LLC
Debt Instrument [Line Items]
Number of shares issued (in shares)			15,018,729
Consideration received on sale of stock			$ 4,600,000
Common Stock | 2019 Aspire Purchase Agreement
Debt Instrument [Line Items]
Period of purchase stock		30 months
Private Placement | Aspire Capital Fund, LLC
Debt Instrument [Line Items]
Purchase amount of shares authorized	$ 30,000,000	$ 30,000,000
Number of shares issued (in shares)			11,007,726
Private Placement | Common Stock | Aspire Capital Fund, LLC
Debt Instrument [Line Items]
Period of purchase stock	30 months

REVENUE (Details)

REVENUE (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue	$ 431,000	$ 1,209,000
Revenue included in the beginning balance of Contract liability	0	100,000
AI-based products and services
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue	324,000	425,000
Advertising and other
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue	$ 107,000	$ 784,000

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Assumptions Used in Calculating the Fair Value of Warrants (Details) - Fair Value, Inputs, Level 3 - China Branding Group Limited	Mar. 31, 2020	Dec. 31, 2019
Expected volatility | CBG Financing Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0.8500	0.8500
Expected volatility | CBG Acquisition Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0.7500	0.7500
Risk-free interest rate | CBG Financing Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0.0033	0.0160
Risk-free interest rate | CBG Acquisition Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0.0052	0.0165
Expected remaining term (years) | CBG Financing Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, expected remaining term	14 days	22 days
Expected remaining term (years) | CBG Acquisition Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, expected remaining term	3 years 5 months 23 days	3 years 8 months 19 days

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details)	Mar. 31, 2020future_event
Fair Value Disclosures [Abstract]
Estimated future equity financing events	1

FAIR VALUE MEASUREMENTS - Estim

FAIR VALUE MEASUREMENTS - Estimate of Expected Volatility and Stock Price (Details) - CBG Acquisition Warrants - China Branding Group Limited $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Changes in fair value resulting from 5% increase in expected volatility	$ 0
Changes in fair value resulting from 5% decrease in expected volatility	$ 58

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in Fair Value of Warrants Accounted for as Derivative Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Warrant liabilities
Contingent Consideration
Balance at beginning of period	$ 115	$ 1,383
Change in fair value	(57)	(1,268)
Balance at end of period	58	115
Earnout payment liabilities | Vegas.com LLC
Contingent Consideration
Balance at beginning of period	1,086
Interest accrued on unpaid balance	17
Balance at end of period	$ 1,103	$ 1,086

TRADE ACCOUNTS RECEIVABLE (Deta

TRADE ACCOUNTS RECEIVABLE (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gross accounts receivable balance	$ 3,762	$ 4,171
Allowance for bad debt	(2,222)	(2,207)
Accounts receivable, net	$ 1,540	$ 1,964
AI-based products and services | Product Concentration Risk
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of gross trade receivables	63.00%

INVESTMENT IN UNCONSOLIDATED _2

INVESTMENT IN UNCONSOLIDATED AFFILIATES (Details) $ in Millions	1 Months Ended
	Jun. 30, 2018USD ($)entity	Mar. 31, 2020
Noncontrolling Interest [Line Items]
Number of consolidated VIEs | entity	1
Sharecare
Noncontrolling Interest [Line Items]
Ownership percentage in unconsolidated affiliate		4.60%
All-in-one Cloud Net Technology, Co
Noncontrolling Interest [Line Items]
Interest in VIE acquired	20.00%
Payments to acquire VIE | $	$ 1

PREPAID EXPENSE AND OTHER CUR_3

PREPAID EXPENSE AND OTHER CURRENT ASSETS (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Prepaid Expense and Other Current Assets
Other receivables	$ 3,679	$ 3,712
Prepaid expense	649	633
Deposits	12	7
Other current assets	277	271
Total	$ 4,617	$ 4,623

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Total property, equipment and software	$ 5,888		$ 6,022
Less accumulated depreciation	(5,708)		(5,681)
Total property, equipment and software, net	180		341
Depreciation (and amortization of software) expense	$ 100	$ 200
Computers and equipment
Property, Plant and Equipment [Line Items]
Estimated Life (Years)	3 years
Total property, equipment and software	$ 987		989
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated Life (Years)	3 years
Total property, equipment and software	$ 23		23
Software
Property, Plant and Equipment [Line Items]
Estimated Life (Years)	3 years
Total property, equipment and software	$ 4,867		4,896
Leasehold improvements
Property, Plant and Equipment [Line Items]
Estimated Life (Years)	10 years
Total property, equipment and software	$ 11		$ 114

LEASES - Narrative (Details)

LEASES - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Current portion of operating lease liability	$ 316
Cash paid for operating lease liabilities		$ 100
Weighted-average remaining lease term	16 months
Weighted-average discount rate	12.00%
Gain on lease termination	$ 1,538	$ 0

LEASES - Lease Expense (Details

LEASES - Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease expense	$ 394	$ 318
Short-term lease expense	75	66
Lease expense	$ 469	$ 384

LEASES - Maturity of Lease Liab

LEASES - Maturity of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Operating lease liabilities maturing during the next:
One year	$ 337
Two years	84
Total undiscounted cash flows	421
Present value of cash flows	395
Lease liabilities on balance sheet:
Short-term	316
Long-term	79	$ 4,650
Present value of cash flows	$ 395

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2020	Dec. 31, 2019
Finite-lived intangible assets
Gross Amount		$ 1,324	$ 1,324
Accumulated Amortization		(961)	(942)
Net Amount		363	382
Total intangible assets
Gross Amount		1,451	1,451
Net Amount		490	509
Amortization expense	$ 100
License to operate in China
Indefinite-lived intangible assets
Indefinite lived intangible assets		127	127
Domain names
Finite-lived intangible assets
Gross Amount		1,256	1,256
Accumulated Amortization		(893)	(874)
Net Amount		363	382
Other intangible assets
Finite-lived intangible assets
Gross Amount		68	68
Accumulated Amortization		(68)	(68)
Net Amount		$ 0	$ 0

INCOME TAX (Details)

INCOME TAX (Details)	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Effective tax rate	0.00%

DEBT - Short-Term Debt Narrativ

DEBT - Short-Term Debt Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Apr. 12, 2017
Short-term Debt [Line Items]
Note payable	$ 3,000,000	$ 3,000,000
Principal and accrued interest	$ 3,300,000
Short-term note payable to private lender
Short-term Debt [Line Items]
Note payable			$ 3,000,000
Fee payable in relation to short-term note payable			115,000
Daily interest accrued on unpaid balance after maturity			$ 500

DEBT - Schedule of Debt Instrum

DEBT - Schedule of Debt Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Loans Payable
Debt Instrument [Line Items]
Loan due May 2020	$ 11,931	$ 12,025

DEBT - Long-Term Debt Narrative

DEBT - Long-Term Debt Narrative (Details) - USD ($)	May 15, 2019	Sep. 28, 2018	Jun. 29, 2018	Apr. 30, 2018	Sep. 20, 2016	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019	Sep. 24, 2015
Loans Payable
Debt Instrument [Line Items]
Original principal amount					$ 35,500,000				$ 27,500,000
Additional principal amount					$ 8,000,000
Interest rate floor of variable rate						2.00%
Effective interest rate						13.00%
Debt outstanding						$ 11,931,000	$ 12,025,000
LIBOR | Loans Payable
Debt Instrument [Line Items]
Basis spread on variable rate				8.50%		11.00%
Financing Agreement | Loans Payable
Debt Instrument [Line Items]
Basis spread on variable rate		11.00%
Prepayment of debt		$ 8,000,000		$ 8,000,000
Exit fee payable in relation to Loan		$ 3,500,000		$ 3,500,000
Exit fee payment period				60 days
Closing fee				$ 413,000
Extension period for debt repayment (up to)			3 months
Debt outstanding	$ 10,000,000
Sixth Financing Amendment | Loans Payable
Debt Instrument [Line Items]
Interest rate floor of variable rate						2.00%
Maximum business days after effective date	5 days
Maximum business days after effective date to sell investment	5 days
Increase in principal due from insurance payments received								$ 1,100,000
Sixth Financing Amendment | LIBOR | Loans Payable
Debt Instrument [Line Items]
Basis spread on variable rate						8.50%
First Two Months | Financing Agreement | Loans Payable
Debt Instrument [Line Items]
Prepayment of debt			$ 250,000
Third Month | Financing Agreement | Loans Payable
Debt Instrument [Line Items]
Prepayment of debt			$ 500,000
Discontinued Operations, Disposed of by Sale | Vegas.com LLC
Debt Instrument [Line Items]
Aggregate purchase price	$ 30,000,000

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Narrative (Details) - USD ($)	May 28, 2020	Apr. 09, 2020	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	May 26, 2020	Mar. 05, 2020
Loss Contingencies [Line Items]
Gain on lease termination			$ 1,538,000	$ 0
Current portion of operating lease liability			316,000
Vegas.com LLC
Loss Contingencies [Line Items]
Accrued earnout payment			$ 1,100,000		$ 1,100,000
Office Space
Loss Contingencies [Line Items]
Security deposit							$ 300,000
Subsequent Event
Loss Contingencies [Line Items]
Damages sought		$ 1,100,000
Warrants (in shares)						6,641,558
CBG Financing Warrants | Subsequent Event | China Branding Group Limited
Loss Contingencies [Line Items]
Warrant, exercise price (usd per share)	$ 0.30
Warrants (in shares)	6,601,558

STOCKHOLDERS' EQUITY, STOCK-B_3

STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE - Narrative (Details) - USD ($)	Mar. 03, 2020	Mar. 31, 2020	Mar. 29, 2019
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option award expiration period		10 years
Aspire Capital Fund, LLC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares issued (in shares)		15,018,729
Aspire Capital Fund, LLC | Private Placement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase amount of shares authorized	$ 30,000,000		$ 30,000,000
Number of shares issued (in shares)	2,374,545
Purchase amount of shares authorized (in shares)	250,000
Purchase price covenant, consecutive trading days	10 days
Aggregate purchase price payable, daily maximum	$ 500,000
Maximum daily increase in shares for purchase (in shares)	2,000,000
Percentage of aggregate shares of common stock	30.00%
Percentage of closing price of common stock	80.00%
Percentage of volume-weighted average price of common stock	97.00%
Threshold minimum stock price (in dollars per share)	$ 0.25
Shares authorized in transaction (in shares)	11,007,726
Shares authorized, percentage of shares of common stock	19.99%
Minimum price per share to maintain average purchase price (in dollars per share)	$ 0.4879
Number of shares issued (in shares)		11,007,726
Aspire Capital Fund, LLC | Private Placement | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of purchase stock	30 months
China Branding Group Limited | CBG Acquisition Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity interests issued (in shares)		40,000
Exercise price (usd per share)		$ 10
China Branding Group Limited | CBG Financing Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity interests issued (in shares)		4,896,313
Exercise price (usd per share)		$ 3

STOCKHOLDERS' EQUITY, STOCK-B_4

STOCKHOLDERS' EQUITY, STOCK-BASED COMPENSATION AND NET LOSS PER SHARE - Stock Options Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares
Stock Options
Shares
Outstanding at beginning of period (in shares) | shares	10,359,079
Forfeited, cancelled or expired (in shares) | shares	(68,250)
Outstanding at end of period (in shares) | shares	10,290,829
Options exercisable (in shares) | shares	9,900,705
Weighted-Average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 4.20
Forfeited, cancelled or expired (in dollars per share) | $ / shares	3.07
Outstanding at end of period (in dollars per share) | $ / shares	4.21
Options exercisable (in dollars per share) | $ / shares	$ 4.35
Weighted-Average Remaining Contractual Term (in years)
Outstanding (term)	6 years 6 months
Options exercisable (term)	6 years 4 months 24 days
Aggregate Intrinsic Value (in thousands)
Outstanding | $	$ 0
Options exercisable | $	$ 0
China Cash Bonus Awards
Shares
Outstanding at beginning of period (in shares) | shares	1,087,500
Forfeited, cancelled or expired (in shares) | shares	(114,500)
Outstanding at end of period (in shares) | shares	973,000
Options exercisable (in shares) | shares	817,000
Weighted-Average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 5.20
Forfeited, cancelled or expired (in dollars per share) | $ / shares	5.40
Outstanding at end of period (in dollars per share) | $ / shares	5.18
Options exercisable (in dollars per share) | $ / shares	$ 5.20
Weighted-Average Remaining Contractual Term (in years)
Outstanding (term)	5 years 3 months 18 days
Options exercisable (term)	4 years 9 months 18 days
Aggregate Intrinsic Value (in thousands)
Outstanding | $	$ 0
Options exercisable | $	$ 0

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Related Party Transaction [Line Items]
Receivables from related parties	$ 531	$ 0
Management | Advances To Senior Management
Related Party Transaction [Line Items]
Receivables from related parties	$ 500

SEGMENT INFORMATION (Details)

SEGMENT INFORMATION (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)segment	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment	1
Certain Financial Information
Revenue	$ 431	$ 1,209
Adjusted EBITDA	(1,895)	(5,276)
Adjusted EBITDA	(1,895)	(5,276)
Depreciation and amortization	(90)	(325)
Share-based compensation expense	(35)	(325)
Other expense (income), net	1	45
Other loss (gain)	(1,465)	26
Operating loss	(3,484)	(5,855)
Other income (expense)
Interest expense	(461)	(387)
Other income (expense), net	0	(45)
Gain on lease termination	1,538	0
Change in fair value of warrant liability	57	(1,416)
Other gain (loss), net	(73)	(26)
Total other income (expense), net	1,061	(1,874)
Loss from continuing operations before income taxes	(2,423)	(7,729)
Assets	11,996		$ 14,827
Technology & Data Intelligence
Other income (expense)
Capital expenditures	100
Operating Segments | Technology & Data Intelligence
Certain Financial Information
Revenue	324	425
Adjusted EBITDA	(690)	(2,659)
Adjusted EBITDA	(690)	(2,659)
Corporate entity and other business units
Certain Financial Information
Revenue	107	784
Adjusted EBITDA	(1,205)	(2,617)
Adjusted EBITDA	(1,205)	$ (2,617)
Continuing Operations
Other income (expense)
Assets	11,996		14,827
Continuing Operations | Operating Segments | Technology & Data Intelligence
Other income (expense)
Assets	7,040		7,450
Continuing Operations | Corporate entity and other business units
Other income (expense)
Assets	$ 4,956		$ 7,377

DISCONTINUED OPERATIONS (Detail

DISCONTINUED OPERATIONS (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	May 15, 2019
Line items constituting pretax profit or loss
Loss from discontinued operations	$ 0	$ (1,123)
Discontinued Operations, Disposed of by Sale | VDC Transaction
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate purchase price			$ 30,000
Line items constituting pretax profit or loss
Revenue		18,254
Cost of revenue (excluding depreciation and amortization)		2,776
Selling, general and administrative		10,877
Technology and development		2,198
Depreciation, amortization and impairments		2,147
Other operating expense		245
Other expense (income) and loss (gain), net		1,134
Loss from discontinued operations before income taxes		(1,123)
Benefit from income taxes		0
Loss from discontinued operations		$ (1,123)

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	May 28, 2020	Apr. 09, 2020	Mar. 03, 2020	Apr. 27, 2020	Mar. 31, 2020	Mar. 31, 2019	Jul. 03, 2020	May 26, 2020	Mar. 05, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Common stock, shares authorized (shares)					100,000,000					100,000,000
Common stock, shares outstanding (shares)					66,133,888					51,055,159
Gain on lease termination					$ 1,538,000	$ 0
Current portion of operating lease liability					$ 316,000
Subsequent Event
Subsequent Event [Line Items]
Common stock, shares outstanding (shares)							99,408,916
Shares allowed for purchase (in shares)								10,300,000
Warrants (in shares)								6,641,558
Damages sought		$ 1,100,000
Aspire Capital Fund, LLC
Subsequent Event [Line Items]
Number of shares issued (in shares)					15,018,729
Consideration received on sale of stock					$ 4,600,000
Private Placement | Aspire Capital Fund, LLC
Subsequent Event [Line Items]
Number of shares issued (in shares)					11,007,726
Shares authorized, percentage of shares of common stock			19.99%
Minimum price per share to maintain average purchase price (in dollars per share)			$ 0.4879
Purchase amount of shares authorized (in shares)			250,000
Aggregate purchase price payable, daily maximum			$ 500,000
Percentage of aggregate shares of common stock			30.00%
Percentage of volume-weighted average price of common stock			97.00%
Threshold minimum stock price (in dollars per share)			$ 0.25
Private Placement | Aspire Capital Fund, LLC | Subsequent Event
Subsequent Event [Line Items]
Number of shares issued (in shares)				41,853,345
Consideration received on sale of stock				$ 30,000,000
Shares authorized, percentage of shares of common stock		19.99%
Minimum price per share to maintain average purchase price (in dollars per share)		$ 0.3950
Purchase amount of shares authorized (in shares)		500,000
Aggregate purchase price payable, daily maximum		$ 1,000,000
Percentage of aggregate shares of common stock		30.00%
Percentage of volume-weighted average price of common stock		95.00%
Threshold minimum stock price (in dollars per share)		$ 0.15
Over-Allotment Option | Aspire Capital Fund, LLC | Subsequent Event
Subsequent Event [Line Items]
Number of shares issued (in shares)		13,220,164
Office Space
Subsequent Event [Line Items]
Security deposit									$ 300,000
China Branding Group Limited | CBG Financing Warrants | Subsequent Event
Subsequent Event [Line Items]
Warrants (in shares)	6,601,558
Warrant, exercise price (usd per share)	$ 0.30